Cargando…

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA

The Vasti therapy is highly effective in the management of benign prostate Hyperplasia. It deceases the weight-of prostate, residual urine and free serum testosterone level.

Detalles Bibliográficos
Autores principales:	Gupta, Shivaji, Prasad, G.C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 1997
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331161/ https://www.ncbi.nlm.nih.gov/pubmed/22556789

Ejemplares similares

A Conceptual Study on Vasti Effect
por: Gupta, P.K., et al.
Publicado: (2001)

PA03.07. A clinical comparative study of Matra Vasti and Vaitran Vasti in the treatment of Gridhrasi w.s.r to Sciatica
por: Gupta, Charu, et al.
Publicado: (2013)

Clinical evaluation of Lekhaniya Kashaya Vasti in the management of Sthaulya (obesity)
por: Antiwal, Meera, et al.
Publicado: (2014)

Role of Uttara Vasti with Trivrit and Lasuna oil in the management of primary dysmenorrhea
por: Jahan, Shabnam, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Benign Prostatic Hyperplasia
Publicado: (2015)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Effect of Grīvā Vasti in management of Grīvā Asthi Sandhi Gata Vāta (Cervical Spondylosis)
por: Pandey, Yogesh Kumar, et al.
Publicado: (2013)

Lasers are superfluous for the surgical management of benign prostatic hyperplasia in the developing world
por: Gupta, Narmada P., et al.
Publicado: (2009)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

A Clinical study of Matra Vasti and an ayurvedic indigenous compound drug in the management of Sandhigatavata (Osteoarthritis)
por: Shah, Mayuri R., et al.
Publicado: (2010)

The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia
por: Gandhi, Jason, et al.
Publicado: (2017)

Value for Money in Disease Management of Benign Prostatic Hyperplasia
por: Curtiss, Frederic R.
Publicado: (2004)

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia
por: Rahman, Fakhri, et al.
Publicado: (2019)

Management of Benign Prostatic Hyperplasia: Could Dietary Polyphenols Be an Alternative to Existing Therapies?
por: Eleazu, Chinedum, et al.
Publicado: (2017)

Chromosomal aberrations in benign prostatic hyperplasia patients
por: Altok, Muammer, et al.
Publicado: (2016)

The relationship between additional heads of the quadriceps femoris, the vasti muscles, and the patellar ligament
por: Olewnik, Łukasz, et al.
Publicado: (2022)

Nephrogenic adenoma of the prostate after laser therapy of benign prostatic hyperplasia()()
por: Friedman, Gabriel Teitelbaum, et al.
Publicado: (2020)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Gokshuradi Vati and Dhanyaka-Gokshura Ghrita Matra Basti in the management of Benign Prostatic Hyperplasia
por: Bhalodia, Shreyas G., et al.
Publicado: (2012)

Review of Current Laser Therapies for the Treatment of Benign Prostatic Hyperplasia
por: Osterberg, E. Charles, et al.
Publicado: (2013)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
por: Radwan, Ahmed, et al.
Publicado: (2020)

The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary)
por: Sabnis, Ravindra Bhalchandra, et al.
Publicado: (2021)

Recent advances in managing benign prostatic hyperplasia: The Rezūm System
por: Guelce, Dominique, et al.
Publicado: (2018)

Modern best practice in the management of benign prostatic hyperplasia in the elderly
por: Bortnick, Eric, et al.
Publicado: (2020)

A Scoping Review of the Management of Benign Prostate Hyperplasia in Africa
por: Zubair, Abdulahi, et al.
Publicado: (2022)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Current Applications of Artificial Intelligence in Benign Prostatic Hyperplasia
por: Shah, Milap, et al.
Publicado: (2022)

Intraprostatic ozone therapy: A minimally invasive approach in benign prostatic hyperplasia
por: Hussain, Shabbir, et al.
Publicado: (2017)

Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia
por: Elgohary, Hany M, et al.
Publicado: (2017)

Rezum Therapy for Benign Prostatic Hyperplasia: Dubai’s Initial Experience
por: Rowaiee, Rashed, et al.
Publicado: (2021)

Measurement of autophagy flux in benign prostatic hyperplasia in vitro
por: Oh, Sung-hee, et al.
Publicado: (2020)

Three-dimensional measurement and analysis of benign prostatic hyperplasia
por: Feng, Yankun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o3nsm03mb2ejtgg8p5k2acg0pn